In addition to monetary damages and the guilty pleas, the government is seeking to transform the maker of OxyContin into a public benefit company that would fund efforts to curb opioid abuse and give away drugs to prevent overdose deaths.
Nearly all of the states, plus five territories and the District of Columbia, are seeking an aggregate of $2.156 trillion from the maker of the opioid painkiller OxyContin, according to documents filed in the U.S. Bankruptcy Court Monday.
3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed.
The company filed for Chapter 11 Monday, but the move was criticized by some, particularly attorneys general in Massachusetts and Connecticut, amid reports that the Sackler family wired about $1 billion to overseas accounts.
Citing unnamed sources, news outlets reported that Purdue would be dissolved to create a new company that would sell OxyContin and use proceeds to pay plaintiffs in more than 2,000 lawsuits filed by governments nationwide.
Citing anonymous sources familiar with the matter, news outlets reported that the family would pay $3 billion toward a proposed $10-12 billion settlement to resolve the more than 2,000 lawsuits.
The outgoing commissioner requested $55 million to aid the agency's fight against the opioid epidemic.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Reuters reported Monday that the maker of OxyContin was considering the filing so that it could negotiate claims with plaintiffs in about 2,000 lawsuits regarding the drug.
BlueCross BlueShield of Tennessee, the largest insurer in the state has announced it will no longer cover prescriptions for what was once a blockbuster pain reliever made by Purdue Pharma.
Investigative journalism lives in some unlikely places, such as on HBO's "Last Week Tonight with John Oliver." This week, host John Oliver — you know, a comedian by trade — took a deep look at the opioid epidemic in America.
Plus, troubles at Juno Therapeutics parallel those of a failed company that many employees came from, while hospitals are starting to install cameras in the OR to monitor patient safety.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
The abuse-deterrent labeling approval for prescription painkillers means they are formulated to make it tougher for patients to abuse.